PPARγ/NF-κB γ /NF- κ B axis contributes to cold-induced resolution of experimental colitis and preservation of intestinal barrier

被引:1
作者
Di, Yuzhu [1 ]
Li, Hui [1 ]
Yang, Jia [2 ]
Feng, Minghao [2 ]
Wang, Shuang [1 ]
Li, Wanying [1 ]
Wang, Xiuqing [1 ]
Zhu, Yuxin [1 ]
Shi, Yan [3 ]
Feng, Rennan [4 ,5 ]
Qu, Bo [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Gastroenterol & Hepatol, Harbin 150000, Peoples R China
[2] Harbin Med Univ, Coll Bioinformat Sci & Technol, Dept Syst Biol, Harbin 150086, Peoples R China
[3] Harbin Inst Technol, Lab Space Environm & Phys Sci, Harbin 150028, Peoples R China
[4] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin 150081, Heilongjiang, Peoples R China
[5] Harbin Med Univ, Sch Publ Hlth, Key Lab Precis Nutr & Hlth, Minist Educ, Harbin 150081, Heilongjiang, Peoples R China
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2024年 / 1870卷 / 07期
基金
中国国家自然科学基金;
关键词
Cold exposure; IBD; PPAR gamma signaling; Multi-omics; Inflammation; ACTIVATED RECEPTOR-GAMMA; INFLAMMATORY-BOWEL-DISEASE; EXPRESSION; IBD; ROSIGLITAZONE;
D O I
10.1016/j.bbadis.2024.167326
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Environmental stress is a significant contributor to the development of inflammatory bowel disease (IBD). The involvement of temperature stimulation in the development of IBD remains uncertain. Our preliminary statistical data suggest that the prevalence of IBD is slightly lower in colder regions compared to non- cold regions. The observation indicates that temperature changes may play a key role in the occurrence and progression of IBD. Here, we hypothesized that cold stress has a protective effect on IBD. Methods: The cold exposure model for mice was placed in a constant temperature and humidity chamber, maintained at a temperature of 4 degrees C. Colitis models were induced in the mice using TNBS or DSS. To promote the detection methods more clinically, fluorescence confocal endoscopy was used to observe the mucosal micro- circulation status of the colon in the live model. Changes in the colonic wall of the mice were detected using 9.4 T Magnetic Resonance Imaging (MRI) imaging and in vivo fluorescence imaging. Hematoxylin and eosin (H&E) &E) and Immunofluorescence (IF) staining confirmed the pathological alterations in the colons of sacrificed mice. Molecular changes at the protein level were assessed through Western blotting and Enzyme-Linked Immunosorbent Assay (ELISA) assays. RNA sequencing (RNA-seq) and metabolomics (n n = 18) were jointly analyzed to investigate the biological changes in the colon of mice treated by cold exposure. Results: Cold exposure decreased the pathologic and disease activity index scores in a mouse model. Endomicroscopy revealed that cold exposure preserved colonic mucosal microcirculation, and 9.4 T MRI imaging revealed alleviation of intestinal wall thickness. In addition, the expression of the TLR4 and P-P65 - P65 proteins was downregulated and epithelial cell junctions were strengthened after cold exposure. Intriguingly, we found that cold exposure reversed the decrease in ZO-1 and occludin protein levels in dextran sulfate sodium (DSS)- and trinitrobenzenesulfonic acid-induced colitis mouse models. Multi-omics analysis revealed the biological landscape of DSS-induced colitis under cold exposure and identified that the peroxisome proliferator-activated receptor (PPAR) signaling pathway mediates the effects of cold on colitis. Subsequent administration of rosiglitazone (PPAR agonist) enhanced the protective effect of cold exposure on colitis, whereas GW9662 (PPAR antagonist) administration mitigated these protective effects. Overall, cold exposure ameliorated the progression of mouse colitis through the PPAR gamma/NF-kappa B signaling axis and preserved the intestinal mucosal barrier. Conclusion: Our study provides a mechanistic link between intestinal inflammation and cold exposure, providing a theoretical framework for understanding the differences in the prevalence of IBD between the colder regions and non-cold regions, and offering new insights into IBD therapy.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Chitosan Oligosaccharides Alleviate Colitis by Regulating Intestinal Microbiota and PPARγ/SIRT1-Mediated NF-κB Pathway
    Guo, Congcong
    Zhang, Yue
    Ling, Tao
    Zhao, Chongjie
    Li, Yanru
    Geng, Meng
    Gai, Sailun
    Qi, Wei
    Luo, Xuegang
    Chen, Liehuan
    Zhang, Tongcun
    Wang, Nan
    MARINE DRUGS, 2022, 20 (02)
  • [2] PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation
    Dammann, Kyle
    Khare, Vineeta
    Lang, Michaela
    Claudel, Thierry
    Harpain, Felix
    Granofszky, Nicolas
    Evstatiev, Rayko
    Williams, Jonathan M.
    Pritchard, D. Mark
    Watson, Alastair
    Gasche, Christoph
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2015, 1853 (10): : 2349 - 2360
  • [3] Cyclophilin A (CypA) Interacts with NF-κB Subunit, p65/RelA, and Contributes to NF-κB Activation Signaling
    Sun, Shan
    Guo, Mian
    Zhang, James Beiji
    Ha, Albert
    Yokoyama, Kazunari K.
    Chiu, Robert H.
    PLOS ONE, 2014, 9 (08):
  • [4] PPAR γ/Nnat/NF-κB Axis Involved in Promoting Effects of Adiponectin on Preadipocyte Differentiation
    Yang, Wenkai
    Yuan, Wenjin
    Peng, Xinghua
    Wang, Meiling
    Xiao, Jie
    Wu, Cheng
    Luo, Lie
    MEDIATORS OF INFLAMMATION, 2019, 2019
  • [5] Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-κB but not PPAR-γ signaling
    Martinez-Augustin, Olga
    Lopez-Posadas, Rocio
    Gonzalez, Raquel
    Dolores Suarez, Maria
    Zarzuelo, Antonio
    Sanchez de Medina, Fermin
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (05) : 363 - 372
  • [6] Aesculin protects against DSS-Induced colitis though activating PPARγ and inhibiting NF-κB pathway
    Tiana, Xinlei
    Peng, Zhonglu
    Luo, Shangpeng
    Zhang, Shaolong
    Li, Baohui
    Zhou, Changlin
    Fan, Hongye
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 857
  • [7] Gracillin Suppresses Intestinal Epithelial Inflammation and Improves Intestinal Barrier in IBD via the SDHB/NF-κB Axis
    Hou, Hongwei
    Chen, Min
    Yan, Yongxin
    Wang, Fengli
    Liu, Jun
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (09) : 4723 - 4731
  • [8] Tetramethylpyrazine improves oxazolone-induced colitis by inhibiting the NF-κB pathway
    Lu, Yunmin
    Zhu, Meiying
    Chen, Wei
    Yin, Li
    Zhu, Jinshui
    Chen, Niwei
    Chen, Weixiong
    CLINICAL AND INVESTIGATIVE MEDICINE, 2014, 37 (01):
  • [9] A gut feeling of the PXR, PPAR and NF-κB connection
    Wahli, W.
    JOURNAL OF INTERNAL MEDICINE, 2008, 263 (06) : 613 - 619
  • [10] Roles of PPARγ/NF-κB Signaling Pathway in the Pathogenesis of Intrahepatic Cholestasis of Pregnancy
    Zhang, Yan
    Hu, Lingqing
    Cui, Yan
    Qi, Zhigang
    Huang, Xiaoping
    Cai, Liyi
    Zhang, Ting
    Yin, Yongxiang
    Lu, Zhiyi
    Xiang, Jingying
    PLOS ONE, 2014, 9 (01):